CEDARHURST, N.Y., Aug. 9, 2023 /PRNewswire/ — The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of NovoCure Limited (NasdaqGS: NVCR), if they purchased the Company’s securities between January 5, 2023 to June 5, 2023, inclusive (the “Class Period”)….
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.